News & Events
Dr. Hafler Discusses Breakthrough Study on CBS
Dr. David Hafler was featured on CBS This Morning for his involvement in a recent research study linking sodium to autoimmune diseases.
In Memoriam: Gilbert H. Glaser 1920-2012
Gilbert H. Glaser, the founding chair of the Department of Neurology at Yale and a member of the faculty since 1952, died on January 21, 2012. Dr. Glaser was professor emeritus at the School of Medicine and an international authority in epilepsy. He is widely acknowledged as one of the founders of neurology as an independent discipline.
Yale Neurologists Participate in Breakthough Multiple Sclerosis DNA Study
Dr. David Hafler, Chairman of the Department of Neurology, published and participated in one of the largest gene studies of multiple sclerosis, comparing DNA from nearly 10,000 people with multiple MS, with DNA from more than 17,000 unrelated, healthy individuals. The study was published in the August 11, 2011 issue of Nature.
Neurologist is named first Zimmerman and Spinelli Professor
David M. Greer, M.D., M.A., a specialist in the areas of coma, neurocritical care, stroke, and neuroimaging, was named the inaugural Dr. Harry M. Zimmerman and Dr. Nicholas and Viola Spinelli Associate Professor of Neurology.
Dr. Hafler Receives American Academy of Neurology's Highest Honor for Multiple Sclerosis Research
The American Academy of Neurology (AAN) is awarding the 2010 John Dystel Prize for Multiple Sclerosis Research to David A. Hafler, MD, with Yale University. Hafler will receive the award during the AAN’s 62nd Annual Meeting in Toronto, held April 10 through April 17, 2010. The John Dystel Prize recognizes a significant contribution to research in the understanding, treatment, or prevention of multiple sclerosis.
Yale Neurologists Show Effectiveness of Rituximab in Patients with Myasthenia Gravis
Yale neurologists Richard Nowak, MD and Jonathan Goldstein, MD presented the results of a small retrospective study involving fourteen patients at the American Academy of Neurology Annual meeting in Toronto showing the effectiveness of rituximab in patients with refractory myasthenia gravis.
Yale Neurology Resident Heads to Haiti
Three neurologists rushed to Haiti help with patient care in the aftermath of the Jan. 12 earthquake. Jeffrey K. Bigelow, MD, MPH, currently a PGY-4 neurology resident at Yale-New Haven Hospital, was one of the earliest to arrive.
Leading Epileptologist Susan S. Spencer, MD, Dies
The epilepsy community suffered a devastating loss with the news that Susan S. Spencer, MD, died suddenly from an acute intestinal illness on May 21, while vacationing in Utah. At the time of her death, Dr. Spencer, an internationally recognized expert in epilepsy, was a professor of neurology and neurosurgery and co-director of the Yale Epilepsy Program at the Yale School of Medicine.
VA Honors Yale Neurologist Waxman
Yale neurologist Stephen G. Waxman received the Department of Veterans Affairs’ William S. Middleton Award on April 29, 2009 at ceremonies that included a reception at the U.S. Capitol in Washington.
Yale researchers find new piece in Alzheimer’s puzzle
Yale researchers have filled in a missing gap on the molecular road map of Alzheimer’s disease. In the Feb. 26 issue of the journal Nature, the Yale team reports that cellular prion proteins trigger the process by which amyloid-beta peptides block brain function in Alzheimer’s patients.
New York Times Features Dr. Hafler's Research
A recent New York Times article on advances in understanding multiple sclerosis, features the Whole Genome Association study, of which Neurology Department Chair Dr. David Hafler is a principal investigator.
Yale Neurology Cited for Advances in Lancet
Papers published by clinicians and clinical researchers in Yale School of Medicine’s Department of Neurology have been cited as among the most important the past year in three crucial areas—stroke, movement disorders, and multiple sclerosis—in a survey of recent advances in Lancet Neurology.
